Table 7.

Outcomes of sensitivity analysis

Parameter	Number of patients (n)	Number of patients (n)	Analysis method	Heterogeneity		OR	95% CI	P-value
	Exp group	Con group		I2 (%)	P-value
ORR
With low quality	252	250	Fixed	0	0.99	2.77	1.88–4.10	<0.00001
Without low quality	213	216	Fixed	0	0.97	2.75	1.79–4.21	<0.00001
With CIK therapy	252	250	Fixed	0	0.99	2.77	1.88–4.10	<0.00001
Without CIK therapy	208	204	Fixed	0	1.00	2.67	1.75–4.08	<0.00001
DCR
With low quality	191	188	Fixed	0	0.89	2.90	1.72–4.90	<0.0001
Without low quality	169	170	Fixed	0	0.92	2.70	1.57–4.64	0.0003

Notes: Con, control group (chemotherapy alone group); Exp, experimental group (chemotherapy plus DC–CIK immunotherapy).

Abbreviations: CI, confidence interval; CIK, cytokine-induced killer cells; DC–CIK, dendritic cells and CIK; DCR, disease control rate; OR, odds ratio; ORR, overall response rate.